• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于自报告药物释放的还原响应型荧光开-关硼二吡咯-喜树碱共轭物

Reduction-responsive fluorescence off-on BODIPY-camptothecin conjugates for self-reporting drug release.

作者信息

Liu Yang, Pei Qing, Chen Li, Li Zhensheng, Xie Zhigang

机构信息

Department of Chemistry, Northeast Normal University, 5268 Renmin Street, Changchun 130024, P. R. China.

出版信息

J Mater Chem B. 2016 Apr 7;4(13):2332-2337. doi: 10.1039/c6tb00009f. Epub 2016 Mar 15.

DOI:10.1039/c6tb00009f
PMID:32263228
Abstract

A reduction-responsive fluorescence off-on theranostic prodrug with self-reporting drug release was constructed based on boron dipyrromethene (BODIPY) and therapeutic drug camptothecin (CPT) with a long flexible disulfide linker. Treatment with dithiothreitol (DTT) induced cleavage of the disulfide bond, followed by intramolecular cyclization reaction to release free CPT, simultaneously perturbing electronic energy transfer (EET) and resulting in enhanced blue and green fluorescence emissions. The changes of the fluorescence ratio over time provided the opportunity for detection and real-time monitoring of drug release at the cellular levels. In addition, the disulfide-linked dyad composed of hydrophobic molecules could self-assemble into stable nanoparticles in aqueous solution, facilitating drug delivery and cancer therapy in vivo due to the enhanced permeation and retention (EPR) effect. Nanomedicines displayed similar fluorescence enhancement in tumor cells. These findings confirm that this dye-disulfide-drug system (DDD) has a significant potential for thiol-activated cancer theranostic and self-reporting drug release in a clinical setting.

摘要

基于硼二吡咯亚甲基(BODIPY)和治疗药物喜树碱(CPT)构建了一种具有自报告药物释放功能的还原响应型荧光开-关诊疗前药,其带有一个长的柔性二硫键连接子。用二硫苏糖醇(DTT)处理会诱导二硫键断裂,随后发生分子内环化反应以释放游离的CPT,同时干扰电子能量转移(EET)并导致蓝色和绿色荧光发射增强。荧光比率随时间的变化为在细胞水平检测和实时监测药物释放提供了机会。此外,由疏水分子组成的二硫键连接二元体在水溶液中可自组装成稳定的纳米颗粒,由于增强的渗透和滞留(EPR)效应,有助于体内药物递送和癌症治疗。纳米药物在肿瘤细胞中表现出类似的荧光增强。这些发现证实,这种染料-二硫键-药物系统(DDD)在临床环境中具有用于硫醇激活的癌症诊疗和自报告药物释放的巨大潜力。

相似文献

1
Reduction-responsive fluorescence off-on BODIPY-camptothecin conjugates for self-reporting drug release.用于自报告药物释放的还原响应型荧光开-关硼二吡咯-喜树碱共轭物
J Mater Chem B. 2016 Apr 7;4(13):2332-2337. doi: 10.1039/c6tb00009f. Epub 2016 Mar 15.
2
A theranostic prodrug based on FRET for real-time drug release monitoring in response to biothiols.一种基于荧光共振能量转移(FRET)的诊疗前体药物,用于响应生物硫醇时的实时药物释放监测。
Mater Sci Eng C Mater Biol Appl. 2017 Mar 1;72:77-85. doi: 10.1016/j.msec.2016.11.056. Epub 2016 Nov 16.
3
Non-invasive, real-time reporting drug release in vitro and in vivo.体外和体内无创实时报告药物释放
Chem Commun (Camb). 2015 Apr 25;51(32):6948-51. doi: 10.1039/c4cc09920f. Epub 2015 Mar 23.
4
Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.基于甲氨蝶呤的两亲性前药纳米聚集体用于联合多种治疗药物和协同癌症治疗。
Acta Biomater. 2018 Sep 1;77:228-239. doi: 10.1016/j.actbio.2018.07.014. Epub 2018 Jul 10.
5
Methotrexate-Camptothecin Prodrug Nanoassemblies as a Versatile Nanoplatform for Biomodal Imaging-Guided Self-Active Targeted and Synergistic Chemotherapy.甲氨蝶呤-喜树碱前药纳米组装体作为一种多功能的纳米平台,用于双模态成像引导的自激活靶向和协同化疗。
ACS Appl Mater Interfaces. 2017 Oct 11;9(40):34650-34665. doi: 10.1021/acsami.7b10027. Epub 2017 Sep 25.
6
Silver Nanoparticles Covered with pH-Sensitive Camptothecin-Loaded Polymer Prodrugs: Switchable Fluorescence "Off" or "On" and Drug Delivery Dynamics in Living Cells.载喜树碱聚合物前药的 pH 敏感型银纳米粒子:活细胞中可切换的荧光“关闭”或“开启”和药物递释动力学。
ACS Appl Mater Interfaces. 2017 Nov 22;9(46):40887-40897. doi: 10.1021/acsami.7b14070. Epub 2017 Nov 9.
7
In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug.通过高稳定性近红外荧光诊疗前药在体和原位跟踪癌症化疗。
J Am Chem Soc. 2014 Mar 5;136(9):3579-88. doi: 10.1021/ja412380j. Epub 2014 Feb 25.
8
Rapidly cell-penetrating and reductive milieu-responsive nanoaggregates assembled from an amphiphilic folate-camptothecin prodrug for enhanced drug delivery and controlled release.由两亲性叶酸-喜树碱前药组装而成的具有快速细胞穿透性和还原环境响应性的纳米聚集体,用于增强药物递送和控释。
Biomater Sci. 2017 Feb 28;5(3):444-454. doi: 10.1039/c6bm00800c.
9
High Drug Loading, Reversible Disulfide Core-Cross-Linked Multifunctional Micelles for Triggered Release of Camptothecin.高载药量、可还原二硫键交联的多功能胶束用于喜树碱的触发释放。
Mol Pharm. 2018 Dec 3;15(12):5479-5492. doi: 10.1021/acs.molpharmaceut.8b00585. Epub 2018 Nov 9.
10
Effect of drug precursor in cell uptake and cytotoxicity of redox-responsive camptothecin nanomedicines.药物前体对氧化还原响应型喜树碱纳米药物细胞摄取及细胞毒性的影响。
Mater Sci Eng C Mater Biol Appl. 2016 Jan 1;58:692-9. doi: 10.1016/j.msec.2015.09.012. Epub 2015 Sep 9.

引用本文的文献

1
Theranostic Fluorescent Probes.诊疗用荧光探针
Chem Rev. 2024 Mar 13;124(5):2699-2804. doi: 10.1021/acs.chemrev.3c00778. Epub 2024 Feb 29.
2
Amino-BODIPY as the ratiometric fluorescent sensor for monitoring drug release or "power supply" selector for molecular electronics.氨基硼二吡咯作为用于监测药物释放的比率荧光传感器或用于分子电子学的“电源”选择器。
RSC Adv. 2019 Aug 13;9(43):25075-25083. doi: 10.1039/c9ra03472b. eCollection 2019 Aug 8.
3
Design Principles Governing the Development of Theranostic Anticancer Agents and Their Nanoformulations with Photoacoustic Properties.
指导具有光声特性的治疗诊断用抗癌药物及其纳米制剂开发的设计原则。
Pharmaceutics. 2022 Feb 4;14(2):362. doi: 10.3390/pharmaceutics14020362.
4
Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy: From intrinsic physicochemical properties to external modification.用于癌症治疗的具有高效药物递送和释放功能的无载体纳米药物:从固有物理化学性质到外部修饰
Bioact Mater. 2021 Jul 6;8:220-240. doi: 10.1016/j.bioactmat.2021.06.035. eCollection 2022 Feb.
5
Cytotoxicity of Amino-BODIPY Modulated via Conjugation with 2-Phenyl-3-Hydroxy-4(1H)-Quinolinones.通过与 2-苯基-3-羟基-4(1H)-喹啉酮偶联来调节氨基-BODIPY 的细胞毒性。
ChemistryOpen. 2021 Nov;10(11):1104-1110. doi: 10.1002/open.202100025. Epub 2021 Aug 23.
6
Water-dispersible unadulterated α-mangostin particles for biomedical applications.用于生物医学应用的水分散性纯α-山竹素颗粒。
R Soc Open Sci. 2020 Nov 18;7(11):200543. doi: 10.1098/rsos.200543. eCollection 2020 Nov.
7
Recent advances in construction of small molecule-based fluorophore-drug conjugates.基于小分子的荧光团-药物缀合物构建的最新进展。
J Pharm Anal. 2020 Oct;10(5):434-443. doi: 10.1016/j.jpha.2020.08.006. Epub 2020 Aug 22.
8
Fluorogenic reaction-based prodrug conjugates as targeted cancer theranostics.基于荧光反应的前药缀合物作为靶向癌症诊疗试剂
Chem Soc Rev. 2018 Jan 2;47(1):28-52. doi: 10.1039/c7cs00557a.